RELATIONSHIP OF TIME TO RELAPSE (TTR) AND SURVIVAL POST RELAPSE (SPR): EXPLORATION OF RISK FACTORS FROM THE FOLLOW-UP DATASET OF A RANDOMIZED PBO-CONTROLLED STUDY OF OREGOVOMAB (OV) AS A CONSOLIDATION THERAPY FOR PATIENTS WITH ADVANCED OVARIAN CANCER (OC)
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.